Skip to content
October 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • Global Landmarks to Shine in Teal, Green, and Pink: The Rise of the #LightUpMBC Movement
  • Patient Advocacy and Support

Global Landmarks to Shine in Teal, Green, and Pink: The Rise of the #LightUpMBC Movement

Reynand Wu October 13, 2026 8 minutes read
global-landmarks-to-shine-in-teal-green-and-pink-the-rise-of-the-lightupmbc-movement

NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from general awareness to the urgent reality of metastatic breast cancer (MBC). On October 13, 2026, designated as National Metastatic Breast Cancer Awareness Day, more than 325 landmarks across the globe will be illuminated in the symbolic colors of teal, green, and pink. This coordinated display, known as the #LightUpMBC campaign, aims to bring visibility to the only form of breast cancer that is currently terminal: Stage 4.

Organized by METAvivor Research and Support, the campaign transcends mere symbolism. It serves as a massive fundraising engine and a call to action for a disease that claims the lives of approximately 117 people in the United States every single day. As landmarks from the One World Trade Center in New York to the Mactan-Cebu Airport in the Philippines glow in unison, the message is clear: awareness is no longer enough; research is the only path to survival.

Main Facts: A Global Beacon for the Forgotten Stage

The #LightUpMBC campaign is a multifaceted initiative designed to bridge the gap between the "pink ribbon" culture of early detection and the stark reality of those living with a terminal diagnosis. While traditional breast cancer messaging often focuses on "winning the battle" or "finishing treatment," the metastatic community faces a lifetime of consecutive treatments with no end date.

The Scope of the 2026 Campaign

The scale of the 2026 initiative is unprecedented. The illumination will span:

  • All 50 U.S. States: Ensuring a domestic presence from coast to coast.
  • 20 Countries: Including the United Kingdom, Canada, and the Philippines, marking MBC as a global health priority.
  • 195 Cities: Representing a grassroots effort that has scaled into a metropolitan phenomenon.

The chosen colors—teal, green, and pink—are deeply symbolic. Teal represents healing and spirituality; green represents the triumph of spring over winter and the renewal of life; and pink signifies the breast cancer origin. Together, they represent the unique journey of the metastatic patient.

LightUpMBC Live

Parallel to the physical illuminations, a virtual event titled "#LightUpMBC Live" will stream globally at 8 p.m. ET / 5 p.m. PT. This free broadcast is designed to humanize the statistics. Hosted by Tami Eagle Bowling, a prominent advocate living with MBC for 11 years, and Broadway star Kara Lindsay, the program will feature a blend of patient testimonials, scientific updates, and world-class musical performances. The event is a strategic effort to ensure that even those who cannot visit a landmark in person can participate in the advocacy and fundraising efforts.

Chronology: From a Single Bridge to a Global Phenomenon

The history of #LightUpMBC is a testament to the power of individual legacy. The movement did not begin in a corporate boardroom but rather as the final wish of a young woman named Jessica Moore.

2017: The First Light

In 2017, Jessica Moore was battling Stage 4 breast cancer at the age of 36. Her hope was simple yet profound: to see a local landmark lit up in the MBC awareness colors to show the world that Stage 4 patients existed and needed more than just "pink" platitudes. That year, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up for MBC.

2018–2025: Exponential Growth

Following Jessica’s passing, her best friend Laura Inahara took up the mantle. What began as a localized tribute quickly resonated with a community that felt largely ignored by mainstream Breast Cancer Awareness Month campaigns.

  • The Foundation: Inahara founded the #LightUpMBC campaign to formalize the effort.
  • The Partnership: By partnering with METAvivor Research and Support, the campaign ensured that 100% of the funds raised would go directly to Stage 4 research.
  • The Digital Shift: During the global pandemic, the campaign pivoted to include the "Live" broadcast, which allowed the movement to reach international audiences and include high-profile performers from Broadway and beyond.

2026: The Current Landscape

Today, the campaign has raised over $2.7 million for critical research. The 2026 iteration marks a milestone in geographic reach, with landmarks like the Ness Bridge in Scotland and the Willis Tower in Chicago joining the roster, signaling that the "Stage 4" conversation has finally reached the mainstream architectural and cultural landscape.

Supporting Data: The Urgent Necessity for Targeted Research

To understand why #LightUpMBC is necessary, one must look at the sobering statistics surrounding metastatic disease. Metastatic breast cancer occurs when the cancer spreads beyond the breast to vital organs, most commonly the bones, liver, lungs, or brain.

The Mortality Gap

According to data from the National Cancer Institute’s SEER program, an estimated 42,670 people in the United States are expected to die from breast cancer in 2026. Virtually all of these deaths are the result of metastatic disease. Despite this, historically, only a small fraction of overall breast cancer research funding has been dedicated specifically to the metastatic stage.

The Diagnostic Reality

The pathway to an MBC diagnosis varies, adding to the complexity of the disease:

  1. De Novo Diagnosis: Some patients are diagnosed at Stage 4 from their very first screening.
  2. Recurrence: Others may have been "cancer-free" for years or even decades before the disease returns in a metastatic form.

The Myth of the "Cure"

A critical data point emphasized by METAvivor is the nature of treatment. For MBC patients, treatment is permanent. Even when a scan shows "No Evidence of Disease" (NED), the cancer cells are often still present at a microscopic level, waiting to become resistant to current therapies. This creates a "revolving door" of treatments where patients must constantly switch medications as their cancer evolves.

Official Responses: Voices from the Frontlines

The leadership of METAvivor and the founders of #LightUpMBC emphasize that this campaign is fueled by "patient-driven" advocacy.

Dr. Kelly Shanahan, METAvivor Board President, who has been living with the disease since 2013, highlights the role of hope in the face of terminal statistics. "When I was diagnosed… I certainly didn’t think I’d still be here 13 years later," Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."

Laura Inahara, Founder of #LightUpMBC, reflects on the emotional weight of the campaign. "Jessica Moore hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love," Inahara said. She noted that the campaign does more than raise money; it teaches patients how to advocate for themselves in a healthcare system that often prioritizes early-stage narratives.

Tami Eagle Bowling, Campaign Director and Livestream Host, emphasizes the educational component. By bringing together Tony Award winners like Victoria Clark and scientific experts, the livestream aims to make complex oncology accessible. "We are meeting the people behind the lights," Bowling noted, referring to the live feeds from landmarks where patients will share their personal stories in real-time.

Implications: Shifting the Paradigm of Advocacy

The success of #LightUpMBC suggests a significant shift in how the public consumes health-related advocacy. There is a growing fatigue with "passive awareness" and a move toward "active philanthropy."

Reforming Research Funding

METAvivor’s model is unique in the non-profit sector. By using a rigorous peer-review process that involves both scientific experts and patient advocates, they ensure that the grants they award—funded by events like #LightUpMBC—are focused on projects that will actually extend life. The implication for the future of oncology is a more democratic, patient-centered approach to research priorities.

The Psychological Impact on Patients

For many years, Stage 4 patients reported feeling "pink-washed"—marginalized by a month that celebrated "survivorship" while they faced a terminal prognosis. #LightUpMBC provides a dedicated space for this community to grieve, celebrate, and fight. The visibility of 325 landmarks acts as a massive validation of their existence.

A Model for Other Diseases

The #LightUpMBC framework—combining global architectural participation, high-production digital media, and 100% transparent funding—serves as a potential blueprint for other "orphan" or underfunded stages of common diseases. It demonstrates that a specific, focused message can often be more impactful than a broad, generalized one.

As October 13 approaches, the world prepares to see its most iconic structures in a new light. From the roaring waters of Niagara Falls to the skyline of New York City, the glow of teal, green, and pink serves as a reminder that while metastatic breast cancer currently has no cure, the global community is no longer content to leave its patients in the dark.


To participate: The public is encouraged to visit www.lightupmbc.org to find a local landmark, donate to research, or access the link for the October 13 livestream. Photos shared on social media using #LightUpMBC and #METAvivor will be featured as part of the global digital mosaic of support.

About the Author

Reynand Wu

Author

View All Posts

Post navigation

Previous: FDA Approves Landmark Maintenance Triple-Therapy for HER2-Positive Metastatic Breast Cancer: A Comprehensive Analysis

Related Stories

Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Approves Landmark Maintenance Triple-Therapy for HER2-Positive Metastatic Breast Cancer: A Comprehensive Analysis

Sagoh October 13, 2026
navigating-the-new-normal-breast-cancer-canada-launches-comprehensive-survivorship-webinar-series-for-october-2026
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Launches Comprehensive Survivorship Webinar Series for October 2026

Layla Zulfa October 13, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-what-the-science-says
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Science Says

Ali Ikhwan October 12, 2026

Recent Posts

  • Global Landmarks to Shine in Teal, Green, and Pink: The Rise of the #LightUpMBC Movement
  • FDA Approves Landmark Maintenance Triple-Therapy for HER2-Positive Metastatic Breast Cancer: A Comprehensive Analysis
  • Navigating the "New Normal": Breast Cancer Canada Launches Comprehensive Survivorship Webinar Series for October 2026
  • Strengthening Health Diplomacy: WHO Director-General’s State Visit to Jordan Highlights Global Humanitarian Resilience
  • First Tracks Bolsters Pipeline with Promising Early-Stage Celiac Disease Data

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

global-landmarks-to-shine-in-teal-green-and-pink-the-rise-of-the-lightupmbc-movement
  • Patient Advocacy and Support

Global Landmarks to Shine in Teal, Green, and Pink: The Rise of the #LightUpMBC Movement

Reynand Wu October 13, 2026
Set iv fluid intravenous drop saline drip hospital room,Medical Concept,treatment emergency and injection drug infusion care chemotherapy, concept.blue light background,selective focus stock photo
  • Patient Advocacy and Support

FDA Approves Landmark Maintenance Triple-Therapy for HER2-Positive Metastatic Breast Cancer: A Comprehensive Analysis

Sagoh October 13, 2026
navigating-the-new-normal-breast-cancer-canada-launches-comprehensive-survivorship-webinar-series-for-october-2026
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Launches Comprehensive Survivorship Webinar Series for October 2026

Layla Zulfa October 13, 2026
strengthening-health-diplomacy-who-director-generals-state-visit-to-jordan-highlights-global-humanitarian-resilience
  • Breast Cancer Prevention and Lifestyle

Strengthening Health Diplomacy: WHO Director-General’s State Visit to Jordan Highlights Global Humanitarian Resilience

Suro Senen October 13, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.